Skip to main content

Medical Excellence: Novelties in treatment methods and diagnostics

exterior view DHZB German Heart Centre Berlin
Kai Abresch Fotografie

Baby undergoes successful heart surgery without donor blood

At just eleven days old, Lotte is probably the youngest patient ever to undergo successful heart surgery of such complexity without receiving blood from a donor. For the operation at the Deutsches Herzzentrum Berlin (DHZB), a heart-lung machine specially developed for newborns was used. For years, DHZB surgeons and paediatric cardiologists have been working on systems that do not require donor blood. This minimizes the risks of infection and intolerance, and allows patients to recover more quickly. The DHZB is currently the only heart centre worldwide to routinely use these systems. More information about the DHZB can be found here.  More information about the DHZB can be found here.

entrance to Charité Campus Mitte
Charité – Universitätsmedizin Berlin

Charité professor wins 2016 Berlin Science Award

Neuroscientist and stroke expert Professor Ulrich Dirnagl has received the 2016 Berlin Science Award. The accolade pays tribute to his numerous research contributions in the field of stroke research, cerebral blood flow and cerebral imaging. An internationally renowned scientist, he heads the Experimental Neurology department at the Charité – Universitätsmedizin Berlin and is the director of the Center for Stroke Research Berlin. The award is endowed with 40,000 euros. More information about the Charité can be found here.

Photo: Berlin Institute of Health

New biobank provides foundation for outstanding research

Since December 2016, Berlin has had an ultra-modern biobank, giving the Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) access to a storage facility that is unique in Germany. In future, it will be possible to store up to two million lab samples from patients in the new building at the Campus Virchow-Klinikum and make them available for research purposes. Together with the corresponding treatment data, the biological material will be collected, encrypted and stored. The collection will allow the progression and causes of diseases to be better studied in future, and new personalized therapies to be developed. More information about the Charité can be found here.

Please choose your language
I'm looking for